FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
